We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
National Health Investors
NHI
$3.62B
| $7.98M | 0.01% |
97,928
+5,539
| +6% | +$454K |
|
|
PDCO
977
DELISTED
Patterson Companies, Inc.
PDCO
| $7.97M | 0.01% |
389,313
+12,082
| +3% | +$229K |
|
978
International Bancshares
IBOC
$4.78B
| $7.96M | 0.01% |
184,939
+1,788
| +1% | +$74.1K |
|
979
Valmont Industries
VMI
$9.76B
| $7.92M | 0.01% |
52,887
+826
| +2% | +$117K |
|
980
STAG Industrial
STAG
$7.34B
| $7.91M | 0.01% |
250,447
+23,829
| +11% | +$730K |
|
981
Cleveland-Cliffs
CLF
$6.93B
| $7.89M | 0.01% |
939,301
+484,118
| +106% | +$3.72M |
|
982
Diodes
DIOD
$4.03B
| $7.89M | 0.01% |
139,920
+8,672
| +7% | +$401K |
|
|
GTLS
983
DELISTED
Chart Industries
GTLS
| $7.87M | 0.01% |
116,532
+7,102
| +6% | +$415K |
|
984
Emergent Biosolutions
EBS
$390M
| $7.86M | 0.01% |
145,609
+8,822
| +6% | +$478K |
|
985
Americold
COLD
$4.03B
| $7.85M | 0.01% |
223,875
+14,884
| +7% | +$548K |
|
986
First Bancorp
FBP
$4.48B
| $7.85M | 0.01% |
740,984
+37,884
| +5% | +$396K |
|
987
Bread Financial
BFH
$4.57B
| $7.83M | 0.01% |
87,436
+7,527
| +9% | +$665K |
|
|
WWE
988
DELISTED
World Wrestling Entertainment
WWE
| $7.83M | 0.01% |
120,623
-3,676
| -3% | -$233K |
|
989
SolarEdge
SEDG
$2.96B
| $7.82M | 0.01% |
82,222
+3,653
| +5% | +$312K |
|
|
AAT
990
American Assets Trust
AAT
$1.43B
| $7.8M | 0.01% |
170,012
+18,978
| +13% | +$886K |
|
991
Albany International
AIN
$1.81B
| $7.79M | 0.01% |
102,557
+6,107
| +6% | +$507K |
|
|
ZAYO
992
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $7.79M | 0.01% |
224,667
+4,602
| +2% | +$158K |
|
993
Urban Edge Properties
UE
$2.83B
| $7.78M | 0.01% |
405,600
+13,509
| +3% | +$273K |
|
994
AGNC Investment
AGNC
$12.7B
| $7.77M | 0.01% |
439,433
+7,675
| +2% | +$131K |
|
995
Northwest Natural Holdings
NWN
$2.05B
| $7.77M | 0.01% |
105,370
+6,233
| +6% | +$430K |
|
996
ESCO Technologies
ESE
$8.36B
| $7.76M | 0.01% |
83,926
+4,744
| +6% | +$404K |
|
997
Columbia Sportswear
COLM
$2.97B
| $7.75M | 0.01% |
77,346
+48,053
| +164% | +$4.56M |
|
998
Meritage Homes
MTH
$4.86B
| $7.74M | 0.01% |
253,242
+15,028
| +6% | +$516K |
|
999
Arcosa
ACA
$7.14B
| $7.7M | 0.01% |
172,816
+9,353
| +6% | +$360K |
|
1000
Stepan Co
SCL
$1.45B
| $7.67M | 0.01% |
74,864
+3,950
| +6% | +$385K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.